![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 29, 29895-29901, July 16, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Is Mediated by Arachidonic Acid
B ACTIVATION AND LATE INDUCIBLE NOS EXPRESSION*




From the
Istituto di Farmacologia e Farmacognosia, Università di Urbino "Carlo Bo," Via S. Chiara 27, 61029 Urbino, Italy and the ¶Dipartimento di Biologia, Università di Roma Tre, Viale Marconi 446, 00146 Roma, Italy
Previous results have indicated that lipopolysaccharide (LPS) plus interferon-
(IFN
) inhibits nitric-oxide synthase (NOS)-I activity in glial cells. We report here that arachidonic acid (AA) plays a pivotal role in this response, which was consistently reproduced in different glial cell lines and in primary rat astrocytes. This notion was established using pharmacological inhibitors of phospholipase A2 (PLA2), cytosolic PLA2 (cPLA2) antisense oligonucleotides, and AA add-back experiments. This approach not only allowed the demonstration that AA promotes inhibition of NOS-I activity but also produced novel experimental evidence that LPS/IFN
itself is a potential stimulus for NOS-I. Indeed, LPS/IFN
fails to generate nitric oxide (NO) via NOS-I activation simply because it activates the AA-dependent signal that impedes NOS-I activity. Otherwise, LPS/IFN
promotes NO formation, sensitive to exogenous AA, in cells in which cPLA2 is pharmacologically inhibited or genetically depleted. Because NO suppresses the NF
B-dependent NOS-II expression, inactivation of NOS-I by the LPS/IFN
-induced AA pathway provides optimal conditions for NF
B activation and subsequent NOS-II expression. Inhibition of cPLA2 activity, while reducing the availability of AA, consistently inhibited NF
B activation and NOS-II mRNA induction and delayed NO formation. These responses were promptly reestablished by addition of exogenous AA. Finally, we have demonstrated that the LPS/IFN
-dependent tyrosine phosphorylation of NOS-I and inhibition of its activity are mediated by endogenous AA.
Received for publication, November 21, 2003 , and in revised form, May 11, 2004.
* This work was supported by grants from Ministero dell'Università e della Ricerca Scientifica e Tecnologica, Progetti di Ricerca di Interesse Nazionale (to O. C. and M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
|| To whom correspondence should be addressed. Tel.: 39-06-55176338; Fax: 39-06-55176321; E-mail: colasant{at}uniroma3.it.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Keen, A.-C. Olin, A. Edentoft, E. Gronowitz, and B. Strandvik Airway Nitric Oxide in Patients With Cystic Fibrosis Is Associated With Pancreatic Function, Pseudomonas Infection, and Polyunsaturated Fatty Acids Chest, June 1, 2007; 131(6): 1857 - 1864. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mizuno and T. Nakamura Prevention of Neutrophil Extravasation by Hepatocyte Growth Factor Leads to Attenuations of Tubular Apoptosis and Renal Dysfunction in Mouse Ischemic Kidneys Am. J. Pathol., June 1, 2005; 166(6): 1895 - 1905. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |